Development Level

Tbio 40 | 10,625
Tdark 7 | 7,003
Tchem 5 | 1,890
Tclin 1 | 602

IMPC Term

preweaning lethality, complete... 5 | 633
abnormal bone mineralization 2 | 55
decreased body weight 2 | 174
embryonic lethality prior to t... 2 | 187
short tibia 2 | 82
abnormal bone structure 1 | 131
abnormal gait 1 | 51
abnormal kidney morphology 1 | 30
abnormal seminal vesicle morph... 1 | 47
absent vibrissae 1 | 14
decreased IgG1 level 1 | 4
decreased T cell number 1 | 31
decreased body length 1 | 108
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 49
decreased circulating choleste... 1 | 85
decreased circulating glucose ... 1 | 121
decreased circulating glycerol... 1 | 19
decreased circulating triglyce... 1 | 83
decreased effector memory CD4-... 1 | 6
decreased lean body mass 1 | 195
decreased lumbar vertebrae num... 1 | 62
decreased mean corpuscular hem... 1 | 19
decreased mean corpuscular vol... 1 | 50
decreased spleen weight 1 | 13
decreased threshold for audito... 1 | 32
decreased total body fat amoun... 1 | 186
embryonic lethality prior to o... 1 | 148
enlarged heart 1 | 111
hyperactivity 1 | 108
increased circulating creatini... 1 | 29
increased grip strength 1 | 83
increased heart weight 1 | 37
increased mean corpuscular vol... 1 | 91
increased sacral vertebrae num... 1 | 62
prenatal lethality prior to he... 1 | 64
preweaning lethality, incomple... 1 | 260
vertebral fusion 1 | 23

Disease

ovarian cancer 35 | 8,484
osteosarcoma 31 | 7,933
glioblastoma 25 | 5,572
psoriasis 22 | 6,685
pancreatic ductal adenocarcinoma liver metastasis 20 | 1,795
medulloblastoma, large-cell 18 | 6,234
lung cancer 17 | 4,466
atypical teratoid / rhabdoid tumor 16 | 4,369
Multiple myeloma 14 | 1,327
pediatric high grade glioma 14 | 2,712
diabetes mellitus 12 | 1,663
non-small cell lung cancer 12 | 2,798
ependymoma 11 | 2,514
lung adenocarcinoma 11 | 2,713
Breast cancer 10 | 3,094
astrocytoma 10 | 1,493
pilocytic astrocytoma 10 | 3,086
acute quadriplegic myopathy 9 | 1,157
group 3 medulloblastoma 9 | 2,254
lung carcinoma 9 | 2,844
pancreatic cancer 9 | 2,300
subependymal giant cell astrocytoma 9 | 2,287
invasive ductal carcinoma 8 | 2,950
active Crohn's disease 7 | 918
group 4 medulloblastoma 7 | 1,875
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
juvenile dermatomyositis 7 | 1,189
primitive neuroectodermal tumor 7 | 3,031
tuberculosis 7 | 1,557
Neurodegenerative disease 6 | 383
Pick disease 6 | 1,893
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,988
malignant mesothelioma 6 | 3,162
pituitary cancer 6 | 1,972
posterior fossa group B ependymoma 6 | 1,530
Rheumatoid Arthritis 5 | 1,160
adult high grade glioma 5 | 2,148
astrocytic glioma 5 | 2,241
dermatomyositis 5 | 933
oligodendroglioma 5 | 2,849
Cancer 4 | 2,346
colon cancer 4 | 1,475
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
non primary Sjogren syndrome sicca 4 | 840
primary pancreatic ductal adenocarcinoma 4 | 1,271
Alzheimer's disease 3 | 644
Carcinoma 3 | 2,147
Cardiomyopathy 3 | 110
Myopathy 3 | 128
Polycystic Ovary Syndrome 3 | 332
Waldenstrons macroglobulinemia 3 | 765
atypical teratoid/rhabdoid tumor 3 | 1,095
breast carcinoma 3 | 1,614
hepatocellular carcinoma 3 | 532
medulloblastoma 3 | 1,524
pancreatic carcinoma 3 | 567
posterior fossa group A ependymoma 3 | 1,511
sonic hedgehog group medulloblastoma 3 | 1,482
spina bifida 3 | 1,064
ulcerative colitis 3 | 2,087
AMYOTROPHIC LATERAL SCLEROSIS 1 2 | 49
Amyotrophic lateral sclerosis type 8 2 | 8
Atherosclerosis 2 | 275
Atrial Fibrillation 2 | 110
Barrett's esophagus 2 | 183
Bipolar Disorder 2 | 266
COPD 2 | 113
Cardiomyopathy, Dilated 2 | 47
Charcot-Marie-Tooth disease 2 | 74
Craniofacial Abnormalities 2 | 147
Dengue hemorrhagic fever 2 | 4
Duchenne muscular dystrophy 2 | 602
Epilepsy 2 | 346
Essential Hypertension 2 | 82
Gastroenteritis 2 | 46
Neuropathy 2 | 210
Obesity 2 | 616
Prostatic Neoplasms 2 | 471
Type 2 diabetes mellitus 2 | 189
acute myeloid leukemia 2 | 780
adrenocortical carcinoma 2 | 1,427
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
esophageal adenocarcinoma 2 | 737
gastric cancer 2 | 430
gastric carcinoma 2 | 832
mucosa-associated lymphoid tissue lymphoma 2 | 480
progressive supranuclear palsy 2 | 674
sarcoidosis 2 | 358
systemic lupus erythematosus 2 | 156
tuberculosis and treatment for 6 months 2 | 686
Adenocarcinoma of lung (disorder) 1 | 48
Dubowitz Syndrome 1 | 11
Inflammatory myofibroblastic tumor 1 | 8
Lipoidosis 1 | 19
Mulibrey nanism 1 | 12
Oculogyric crisis 1 | 3
Progressive myoclonus epilepsy 1 | 3
Stomatitis 1 | 19
Syphilis 1 | 18

Tissue

Blood and immune system 53 | 17,995
Cardiovascular System 53 | 17,958
Digestive Tract 53 | 18,473
Endocrine System 53 | 18,512
Female tissues 53 | 18,647
Liver and Pancreas 53 | 18,136
Male tissues 53 | 17,969
Nervous System 53 | 18,561
Respiratory system 53 | 17,484
Skin and soft tissues 53 | 18,115
Urinary Tract 53 | 18,444

Target Family

Non-IDG 28 | 11,971
Enzyme 19 | 4,146
Transcription Factor 3 | 1,400
Epigenetic 2 | 242
Kinase 1 | 634

Reactome Pathway

XBP1(S) activates chaperone ge... 53 | 53
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Protein transport protein Sec61 subunit alpha isoform 1 SEC61A1 Tbio Non-IDG -2.43916 280.2 94
Protein transport protein Sec61 subunit gamma SEC61G Tdark Non-IDG -0.37727 2.21 27
Glycogen synthase kinase-3 alpha GSK3A Tclin Kinase -1.81647 52.3 722
Exostosin-like 3 EXTL3 Tbio Enzyme -2.64135 453.0 177
Hepatoma-derived growth factor HDGF Tbio Epigenetic -2.04271 125.7 182
Wolframin WFS1 Tbio Non-IDG -2.36163 250.2 110
Protein transport protein Sec31A SEC31A Tbio Non-IDG -1.13880 12.4 72
Stress-associated endoplasmic reticulum protein 1 SERP1 Tbio Non-IDG -1.35469 29.5 75
Sulfotransferase 1A3 SULT1A3 Tchem Enzyme -2.34317 249.1 106
Sulfotransferase 1A4 SULT1A3 Tbio Enzyme 249.1 36